Sanofi-Aventis to buy Zentiva minority shares
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis now controls around 96.8% of Zentiva's share capital and will soon initiate squeeze-out procedures to buy the remaining minority shares.